Navigation Links
Controlling the size of nanoclusters: First step in making new catalysts
Date:7/9/2008

UPTON, NY Researchers from the U.S. Department of Energy's (DOE) Brookhaven National Laboratory and Stony Brook University have developed a new instrument that allows them to control the size of nanoclusters groups of 10 to 100 atoms with atomic precision. They created a model nanocatalyst of molybdenum sulfide, the first step in developing the next generation of materials to be used in hydrodesulfurization, a process that removes sulfur from natural gas and petroleum products to reduce pollution.

As reported in the July 9, 2008 online edition of the Journal of Physical Chemistry C, the scientists made size-selected molybdenum sulfide nanoclusters as gaseous ions, and then gently deposited the clusters on a gold surface. The nanoclusters interact weakly with the gold support and therefore remain intact.

"With this new instrument, we can control how many and what type of atoms are in a nanocluster," said Brookhaven chemist Michael White, the principal author of the paper. "This knowledge enables us to make nanoclusters with predetermined size, structure and chemical composition, all which are important for the design of new catalysts."

Currently, molybdenum sulfide nanoparticles are used for hydrodesulfurization and other chemical processes, but it is not known what size is most active or how the reactions occur on small particles. The ability to make model nanocatalysts containing molybdenum sulfide particles of variable size and chemical makeup will allow White and coworkers to understand how current catalysts work and help design the next generation of catalysts.

In the current research, the scientists explored the chemical reactivity of a very stable or "magic" cluster of four atoms of molybdenum and six atoms of sulfur deposited on a gold surface. This small nanocluster is thought to be prototypical of active catalyst particles because all the molybdenum metal atoms are exposed and therefore can react with other molecules. Exploring larger and more reactive nanoclusters will be the next step.

"This was a study to test the capabilities of the newly built instrument," White said. "Now we can do further studies with different nanoclusters to find those that are most reactive and therefore best suited as models for making the most efficient nanocatalysts."


'/>"/>

Contact: Diane Greenberg
greenb@bnl.gov
631-344-2347
DOE/Brookhaven National Laboratory
Source:Eurekalert

Related biology technology :

1. ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
2. Gladstone scientists identify role of tiny RNAs in controlling stem cell fate
3. Presentation of North Americas First Certificate for BS 25999, the New Standard for Business Continuity
4. Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute
5. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings
6. Edmonton to be site of worlds first industrial scale municipal waste-to-ethanol facility
7. ActivBiotics Assignee Issues First Distribution of Cash to Creditors
8. HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
9. Start of First Fingertip Payment Pilot in the Netherlands
10. First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease
11. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , ... May 25, 2016 , ... Scientists at the ... options being tried for mesothelioma may be hampering the research that could lead to ... Click here to read it now. , The team evaluated 98 ...
(Date:5/25/2016)... , ... May 25, 2016 , ... ... Food and Drug Administration (FDA) has granted the company’s orphan drug designation request ... second orphan drug designation granted by the FDA. , Spinocerebellar ataxia is ...
(Date:5/24/2016)... ... ... Last week, Callan Capital, an integrated wealth management firm specializing in asset ... Diego Life Science event at the Estancia La Jolla Resort and Spa. , Over ... Dr. Rich Heyman, former CEO of Aragon and Seragon, and Faheem Hasnain, former CEO ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® ... Farming in 2017 and Beyond. The paper outlines the key trends that are ... industry. , “We’ve witnessed a lot of highs and lows as the precision ...
Breaking Biology Technology:
(Date:3/31/2016)... RATON, Florida , March 31, 2016 ... LEGX ) ("LegacyXChange" or the "Company") ... for potential users of its soon to be launched ... video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide ... the use of DNA technology to an industry that ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):